Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1831003
Max Phase: Preclinical
Molecular Formula: C24H37ClN4
Molecular Weight: 380.58
Molecule Type: Small molecule
Associated Items:
ID: ALA1831003
Max Phase: Preclinical
Molecular Formula: C24H37ClN4
Molecular Weight: 380.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)CCCCNCc1nccc2c3ccccc3n(CC(C)C)c12.Cl
Standard InChI: InChI=1S/C24H36N4.ClH/c1-5-27(6-2)16-10-9-14-25-17-22-24-21(13-15-26-22)20-11-7-8-12-23(20)28(24)18-19(3)4;/h7-8,11-13,15,19,25H,5-6,9-10,14,16-18H2,1-4H3;1H
Standard InChI Key: GQBSAZOCFDSFBN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 380.58 | Molecular Weight (Monoisotopic): 380.2940 | AlogP: 5.06 | #Rotatable Bonds: 11 |
Polar Surface Area: 33.09 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 10.35 | CX LogP: 4.29 | CX LogD: -0.22 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.47 | Np Likeness Score: -0.88 |
1. Chen Z, Cao R, Shi B, Guo L, Sun J, Ma Q, Fan W, Song H.. (2011) Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents., 46 (10): [PMID:21875764] [10.1016/j.ejmech.2011.08.027] |
Source(1):